The WTO approved a deal yesterday to let poorer nations import cheaper generic drugs to fight killer diseases such as AIDS and malaria after days of emotionally charged debate.
The deal plugs a gap in world trade law and allows poorer countries unable to manufacture medicines domestically to override international patents and import cheap generic drugs when they need to.
"The decision that you have just taken is an historic agreement for the WTO," WTO Director-General Supachai Panitchpakdi told member states.
The accord, given a final seal of approval by the WTO's 146-member executive General Council yesterday, means setting aside patents owned by multinational firms that are protected by trade rules.
"I find a special satisfaction in the fact that the decision will be of particular value to the smaller and poorer countries ... in Africa and elsewhere," Supachai said. "It will enable them to make full use of the flexibilities in the WTO intellectual property rules in order to deal with the diseases that ravage their peoples."
An impassioned plea on Friday by African states, who said that thousands were dying as trade envoys bickered, got the talks back on track after a deal agreed on Thursday by the main negotiating body on medicines ran into last-minute problems.
Oppostion
But health activists attacked the accord, hammered out by the US, Brazil, India, Kenya and South Africa, saying it imposed too many conditions on countries seeking to use it.
"Today's WTO agreement that is ostensibly intended to get drugs to the poorest countries does not provide a workable solution," Medicines sans Frontieres (Doctors without Borders) and Oxfam said in a joint statement.
The pact aims to allay US concerns that any waiving of patents could be abused for commercial gain by generic producers such as Brazil and India.
The US, home to many major pharmaceutical firms, had feared they could turn out highly profitable life-style remedies such as Viagra for sale in richer developing nations.
The drugs industry has welcomed the pact as balancing the need for poor states to fight health problems with the demands that WTO members waive patents only to import generic medicines "in good faith" and do not abuse the system for commercial gain.
Steps will be taken to ensure medicine sold to poor countries does not turn up on rich country markets, and a number of richer developing countries -- such as Mexico and South Korea -- will agree to use the system only in dire health emergencies.
Existing world trade rules allowed countries -- developed or developing -- with their own drugs industry to waive patents and issue compulsory licences to generic manufacturers when they face health emergencies.
But the regulations said nothing about states without their own drugs industry and WTO states have been battling over the issue for nearly two years.
A deal before a trade meeting in the Mexican resort of Cancun in less than two weeks was seen as vital to giving new momentum to the WTO's struggling Doha Round of free trade talks.
China has claimed a breakthrough in developing homegrown chipmaking equipment, an important step in overcoming US sanctions designed to thwart Beijing’s semiconductor goals. State-linked organizations are advised to use a new laser-based immersion lithography machine with a resolution of 65 nanometers or better, the Chinese Ministry of Industry and Information Technology (MIIT) said in an announcement this month. Although the note does not specify the supplier, the spec marks a significant step up from the previous most advanced indigenous equipment — developed by Shanghai Micro Electronics Equipment Group Co (SMEE, 上海微電子) — which stood at about 90 nanometers. MIIT’s claimed advances last
ISSUES: Gogoro has been struggling with ballooning losses and was recently embroiled in alleged subsidy fraud, using Chinese-made components instead of locally made parts Gogoro Inc (睿能創意), the nation’s biggest electric scooter maker, yesterday said that its chairman and CEO Horace Luke (陸學森) has resigned amid chronic losses and probes into the company’s alleged involvement in subsidy fraud. The board of directors nominated Reuntex Group (潤泰集團) general counsel Tamon Tseng (曾夢達) as the company’s new chairman, Gogoro said in a statement. Ruentex is Gogoro’s biggest stakeholder. Gogoro Taiwan general manager Henry Chiang (姜家煒) is to serve as acting CEO during the interim period, the statement said. Luke’s departure came as a bombshell yesterday. As a company founder, he has played a key role in pushing for the
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) has appointed Rose Castanares, executive vice president of TSMC Arizona, as president of the subsidiary, which is responsible for carrying out massive investments by the Taiwanese tech giant in the US state, the company said in a statement yesterday. Castanares will succeed Brian Harrison as president of the Arizona subsidiary on Oct. 1 after the incumbent president steps down from the position with a transfer to the Arizona CEO office to serve as an advisor to TSMC Arizona’s chairman, the statement said. According to TSMC, Harrison is scheduled to retire on Dec. 31. Castanares joined TSMC in
EUROPE ON HOLD: Among a flurry of announcements, Intel said it would postpone new factories in Germany and Poland, but remains committed to its US expansion Intel Corp chief executive officer Pat Gelsinger has landed Amazon.com Inc’s Amazon Web Services (AWS) as a customer for the company’s manufacturing business, potentially bringing work to new plants under construction in the US and boosting his efforts to turn around the embattled chipmaker. Intel and AWS are to coinvest in a custom semiconductor for artificial intelligence computing — what is known as a fabric chip — in a “multiyear, multibillion-dollar framework,” Intel said in a statement on Monday. The work would rely on Intel’s 18A process, an advanced chipmaking technology. Intel shares rose more than 8 percent in late trading after the